Skip to main content
Colored pills on the face on money.

IQVIA report: U.S. health system is recovering from pandemic

U.S. medicine spending increased 0.8% on a net price basis to $359 billion, which reflects an increasing gap between list or invoice prices and manufacturer net revenues.
Levy

The U.S. health system demonstrated resilience and flexibility during 2020, recovering toward its pre-pandemic levels of activity and progressing into 2021, even as the backlog of missed or delayed activity remains substantial. This finding comes from a new report by the IQVIA Institute for Human Data Science — The Use of Medicines in the U.S., which also found that medicine supply was largely maintained and spending on medicines increased by less than 1% on a net price basis.

Other key findings in the report include:

Health Services Utilization Index During COVID-19

  • During the first quarter of 2021, the use of key health services — as measured by the IQVIA Health Services Utilization Index — was at 82% of pre-COVID-19 levels, up from a low of 42% at the peak of the first wave of the pandemic in April 2020.

Medicine Use

  • A total of 6.3 billion prescriptions were dispensed in 2020 with growth slowing to 1.7% after adjusting for the increased use of 90-day prescriptions for chronic therapies.

Medicine Spending and Growth Drivers

  • U.S. medicine spending increased 0.8% on a net price basis to $359 billion, which reflects an increasing gap between list or invoice prices and manufacturer net revenues.

Patient Out-of-Pocket Costs and Affordability

  • Out-of-pocket costs in aggregate for all patients, including retail prescriptions and non-retail medicines, increased $1 billion in 2020 to a record $77 billion.

Outlook to 2025

  • Total net spending on medicine is expected to reach $380 to $400 billion in 2025, up from $359 billion in 2020, reflecting a compound annual growth rate of 0% to 3%. 

Learn more by downloading the report and graphic exhibits.

 

X
This ad will auto-close in 10 seconds